Iosat 130 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DB25FKYCN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,613
Award facts
- Contract value 100% obligated
- $1,612.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,612.80 by the Defense Logistics Agency (DLA) on September 26, 2025. The contract, with an ultimate completion date of September 29, 2025, calls for the delivery of IOSAT 130 mg tablets in quantities of 14 units to support federal healthcare needs. This delivery order was issued without a set-aside designation, allowing the vendor to compete on a full and open basis. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities.
As a pharmaceutical wholesaler with a robust federal contracting history, DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. The company's core mission involves providing direct distribution of pharmacy products to support Defense Department healthcare requirements globally. This particular delivery order represents routine procurement activity under the DLA's SPE2DB program, reflecting the agency's ongoing need for pharmaceutical inventory replenishment across its healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FKYCN?
SPE2DB25FKYCN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FKYCN worth?
The government has obligated $1,613 on SPE2DB25FKYCN.
Is contract SPE2DB25FKYCN an order under another contract?
Yes. SPE2DB25FKYCN is a delivery order under SPE2DB24D9801, an indefinite delivery contract.
Was contract SPE2DB25FKYCN competed?
The extent of competition for SPE2DB25FKYCN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award